Siemens Healthineers has appointed Jennifer Kuskowski as the new Head of Government Affairs in the Americas. Jennifer will be responsible for leading regional advocacy efforts in the U.S., Canada and in Latin America on behalf of Siemens Healthineers and Varian, a Siemens Healthineers company. As the new government affairs lead, Jennifer will develop and advance the legislative and political strategy across the Americas, including all interactions involving the U.S. federal government.
Coming from an impressive and diverse background working at the U.S. Capitol, Jennifer is an established policy expert on complex issues including, healthcare, education, and technology. Prior to her role at Siemens Healthineers, Jennifer was a senior advisor to Senate Minority Leader Mitch McConnell, where she negotiated and directed the enactment of health, commerce, and education titles in five bipartisan COVID relief bills and the repeal of the medical device tax. Jennifer also served as the health policy director for the U.S. Senate Committee on Finance and as assistant vice president for the government relations firm Venn Strategies. She holds a bachelor’s degree in Government from Franklin & Marshall College and served in the U.S. Peace Corps for two years addressing health issues in Ecuador.
“I am delighted to welcome Jennifer as the new Head of Government Affairs here at Siemens Healthineers,” said David Pacitti, President and Head of the Americas, Siemens Healthineers. “Her impressive background and nearly two decades of policy, legislative, and political experience are a great asset to the company, and I look forward to collaborating closely with her on leading advocacy efforts at Siemens Healthineers.”
Contact for journalists
Lance Longwell, Siemens Healthineers
Phone: +1 610-883-0788; lance.longwell @siemens-healthineers.com
Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. In fiscal 2021, which ended on September 30, 2021, Siemens Healthineers, which has approximately 66,000 employees worldwide, generated revenue of €18.0 billion and adjusted EBIT of €3.1 billion. Further information is available at www.siemens-healthineers.com.
